European Atrial Fibrillation Trial "EAFT"

Completed

Phase N/A Results

Summary of Purpose

To study the value of anticoagulation in the secondary prevention of stroke in patients with non-rheumatic atrial fibrillation.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 14 November 2000.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • Netherlands Heart Foundation, Bayer Germany and Bayer subsidiaries in participating countries, UK Stroke Association, University Hospitals of Utrecht and Rotterdam.

Trial Design

Randomized, placebo-controlled, international trial of 455 patients at 108 centers.

Contacts

Not available